The American College of Cardiology (ACC), together with other cardiovascular societies, has formally urged the White House Office of Management and Budget (OMB) to withdraw a proposed change to federal research funding, according to a statement issued by the ACC.

The societies' joint objection targets an OMB proposal that would alter how the federal government supports biomedical research. The ACC and its partner organizations argue the change would damage the research pipeline that cardiovascular medicine depends on — from basic discovery through clinical trials.

What the statement says

The ACC's announcement, published on its news channel, calls for the proposal's outright withdrawal rather than revision. That is a notable posture for professional societies, which more typically seek amendments to federal rules. The organizations describe the OMB plan as a threat to research continuity and to the institutions that carry out federally funded cardiovascular science.

For R&D managers at academic medical centers, the stakes are concrete. Federal research grants anchor the budgets of cardiology divisions, fund trainees, and underwrite the trial infrastructure that connects laboratory findings to patient care. Any restructuring of that funding stream forces portfolio decisions: which studies continue, which staff lines hold, and which collaborations pause.

Why societies mobilized

Cardiovascular disease remains the leading cause of death in the United States, and the societies note that progress against it depends on sustained federal investment. The ACC statement frames the OMB proposal as a risk to that trajectory.

The joint appeal also signals coordination across the cardiovascular research community. When multiple societies speak with one voice on funding policy, they amplify pressure on OMB, which oversees the federal budget process and issues government-wide grants guidance.

What remains unknown

The ACC's statement does not, in the available announcement, specify the exact mechanism the OMB proposal would use, the dollar amounts at stake, or a deadline for public comment. Researchers and administrators evaluating exposure should watch the Federal Register and OMB notices for the regulatory text, which will carry the operative details — effective dates, compliance requirements, and cost thresholds.

Until that text is available, lab directors and grants offices can take practical steps: review current federal award terms, map which projects depend on the funding streams the proposal touches, and prepare comment submissions through institutional channels. Professional societies, including the ACC, typically coordinate such comments and circulate templates.

The road ahead

The societies' withdrawal demand now sits with OMB. Whether the office pulls the proposal, revises it, or proceeds to formal rulemaking will shape how academic cardiology programs budget for the coming fiscal cycle.